Actively Recruiting
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Led by Seoul National University Hospital · Updated on 2025-05-18
150
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.
CONDITIONS
Official Title
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing PVI for PAF
You will not qualify if you...
- Aged less than 19 years
- Patients with persistent AF
- Patients with previous ablation or surgery for AF
- Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
- Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
- Patients with contraindication(s) for using oral anticoagulants
- Patients with LA anteroposterior diameter of more than 55 mm
- Patients with left ventricular ejection fraction less than 35%
- Pregnants or those who plan to become pregnant during the study
- Life expectancy less than a year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
Research Team
E
Eue-Keun Choi, M.D. Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here